SCHEMBL4756790

SCHEMBL4756790

CCC(C#N)(CC1C2CCC1CNC2)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 15/20 0.39
CHRM2 P08172 2/20 0.39
CHRM1 P11229 2/20 0.39
CCR1 P32246 1/20 0.36
KCNA3 P22001 1/20 0.36
EBP Q15125 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
CYP2D6 P10635 1/20 0.33
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
OPRM1 P35372 1/20 0.33
DRD3 P35462 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4756747 0.81 CHRM3 (0.47) CHRM3CHRM2CHRM1KCNA3CYP2D6
SCHEMBL4758052 0.79 DRD2 (0.42) CHRM3CHRM2CHRM1CCR1KCNA3
SCHEMBL4757548 0.78 CHRM3 (0.46) CHRM3CHRM2CHRM1CCR1EBP
SCHEMBL4755540 0.74 CCR1 (0.41) CHRM3CHRM2CHRM1CCR1KCNA3
SCHEMBL13271382 0.74 CYP2D6 (0.44) CHRM3CHRM2CHRM1CCR1EBP
SCHEMBL10747164 0.73 CHRM3 (0.40) CHRM3CHRM2CHRM1CCR1EBP
SCHEMBL11630708 0.68 CCR1 (0.45) CHRM3CHRM2CHRM1CCR1KCNA3
SCHEMBL11650019 0.68 SIGMAR1 (0.46) CHRM3CHRM2CHRM1CCR1EBP
SCHEMBL14541984 0.67 EBP (0.51) CHRM3CHRM2CHRM1CCR1KCNA3
SCHEMBL4756753 0.67 CHRM3 (0.50) CHRM3CHRM2CHRM1CYP2D6DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008124575-A1 RENIN INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-10-16 WO claimed
WO-2008117229-A1 MUSCARINIC RECEPTOR ANTAGONISTS RANBAXY LABORATORIES LIMITED (IN) 2008-10-02 WO claimed
WO-2008117229-A1 MUSCARINIC RECEPTOR ANTAGONISTS RANBAXY LABORATORIES LIMITED (IN) 2008-10-02 WO disclosed